Gene Therapy Shows Promise in Treating Hereditary Deafness

Researchers at the University of California, Irvine, have made a groundbreaking discovery in treating hereditary deafness through gene therapy. A multicenter clinical trial found that gene therapy is both safe and effective in restoring biological hearing in children and adults. The study, published in Nature Medicine, involved 10 participants aged between 1.5 and 23.9 years old and showed that gene therapy can restore hearing within a month of drug delivery. The therapy targets specific gene mutations that cause congenital deafness, such as OTOF gene mutations, which affect approximately 2 per 1,000 newborns.

Key Takeaways:

• Gene therapy restores biological hearing in children and adults with hereditary deafness, addressing the root cause of the condition.
• The study, published in Nature Medicine, found that gene therapy is effective in restoring hearing within one month of drug delivery in patients with OTOF gene mutations.
• The therapy targets specific gene mutations, such as OTOF gene mutations, which affect approximately 2 per 1,000 newborns.
• The University of California, Irvine, is leading the way in this research, with Professor Fan-Gang Zeng at the helm, a renowned hearing scientist at the UC Irvine School of Medicine.
• The study's findings have opened doors for treating patients with different hereditary hearing disorders, including those with GJB2 gene mutations.
• The therapy uses adeno-associated virus (AAV)-OTOF gene therapy, delivered through the injection of an Anc80L65 capsid into the cochlea with a needle.
• The study's results have the potential to revolutionize the treatment of hereditary deafness, offering a promising alternative to cochlear implantation.

Statistics:

• 10 participants aged between 1.5 and 23.9 years old were involved in the multicenter clinical trial.
• Up to 50%-60% of hearing loss in newborns is attributed to genetic factors.
• Approximately 2 per 1,000 newborns are affected by congenital deafness caused by OTOF gene mutations.
• The University of California, Irvine, has educated more than 500 medical students and nearly 150 PhD and MS students each year.
• The School of Medicine offers multiple MD, PhD and MS degrees, and students are encouraged to pursue an expansive range of interests and options.

Sources:

• "Gene therapy restores hearing in participants with hereditary deafness," published in Nature Medicine.
• The University of California, Irvine, School of Medicine.
• The University of California, Irvine.
• UC Irvine's website.
• NewsRx.